{
    "nctId": "NCT02618538",
    "briefTitle": "The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.",
    "officialTitle": "Predictive Value of Combined Criteria to Tailor Breast Cancer Screening and New Opportunities From Circulating Markers. The Andromeda Study.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 26600,
    "primaryOutcomeMeasure": "PPV (Positive Predictive Value) of BC risk factors",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All women undergoing a screening mammography in the participating centers.\n\nExclusion Criteria:\n\n* Women unable to give informed consent",
    "sex": "N/A",
    "minimumAge": "46 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}